TTY Biopharm Company Limited (TPEX:4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.50
-0.30 (-0.40%)
Aug 12, 2025, 1:30 PM CST

TTY Biopharm Company Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
1,5831,4501,1291,094831.89924.18
Upgrade
Depreciation & Amortization
198.67194.26193.1180.69162.79153.86
Upgrade
Other Amortization
8.098.097.85.594.493.14
Upgrade
Loss (Gain) From Sale of Assets
10.951.933.280.740.32
Upgrade
Asset Writedown & Restructuring Costs
8.86.8116.180.734.154.58
Upgrade
Loss (Gain) From Sale of Investments
-0.95-8.79-0.21-0.16
Upgrade
Loss (Gain) on Equity Investments
-394.7-400.05-131.34-116.38-135.18-162.87
Upgrade
Provision & Write-off of Bad Debts
-0.451.36-1.933.5613.58-0.1
Upgrade
Other Operating Activities
216.29202.01122.02110.34110.24-15.66
Upgrade
Change in Accounts Receivable
-2.7135.07-116.16-95.4-114.32-36.42
Upgrade
Change in Inventory
-148.36-161.27-56.75-83.95155.12-251.8
Upgrade
Change in Accounts Payable
92.43-10.2111.9596.01-23.07-26.35
Upgrade
Change in Unearned Revenue
20.0320.11-18.89-6.6423.48-0.39
Upgrade
Change in Other Net Operating Assets
-17.372.63-179.8943.55222.24-65.98
Upgrade
Operating Cash Flow
1,5641,3491,0851,2361,256526.35
Upgrade
Operating Cash Flow Growth
43.85%24.33%-12.17%-1.64%138.69%-56.49%
Upgrade
Capital Expenditures
-110.81-125.16-78.35-91.52-60.32-168.11
Upgrade
Sale of Property, Plant & Equipment
2.783.937.019.390.030.01
Upgrade
Cash Acquisitions
--242.87----
Upgrade
Sale (Purchase) of Intangibles
-42.44-9.14-21.23-43.98-13.84-13.75
Upgrade
Investment in Securities
14128.18168.5534.68-14.1308.82
Upgrade
Other Investing Activities
-34.961.49-78.62-41.7-80.5620.26
Upgrade
Investing Cash Flow
-169.95-243.56-2.63-133.14-168.78147.24
Upgrade
Short-Term Debt Issued
-8,05010,28010,8905,4005,400
Upgrade
Long-Term Debt Issued
-500400430-720
Upgrade
Total Debt Issued
7,6508,55010,68011,3205,4006,120
Upgrade
Short-Term Debt Repaid
--8,300-10,200-11,231-5,404-5,246
Upgrade
Long-Term Debt Repaid
--409.77-434.17-421.55-16.54-663.65
Upgrade
Total Debt Repaid
-7,859-8,710-10,634-11,653-5,421-5,910
Upgrade
Net Debt Issued (Repaid)
-209.01-159.7745.83-332.62-20.54210.35
Upgrade
Common Dividends Paid
-1,044-870.28-845.41-745.95-994.6-994.6
Upgrade
Other Financing Activities
-21.39-21.19-16.75-24.83-28.99-22.36
Upgrade
Financing Cash Flow
-1,275-1,051-816.33-1,103-1,044-806.61
Upgrade
Foreign Exchange Rate Adjustments
-136.9997.02-2.66135.85-44.91-65.41
Upgrade
Net Cash Flow
-18151.6263.7135.07-1.48-198.43
Upgrade
Free Cash Flow
1,4531,2241,0071,1441,196358.25
Upgrade
Free Cash Flow Growth
45.82%21.57%-12.00%-4.33%233.86%-68.58%
Upgrade
Free Cash Flow Margin
23.37%20.77%18.29%22.61%26.37%8.49%
Upgrade
Free Cash Flow Per Share
5.834.914.044.594.801.44
Upgrade
Cash Interest Paid
39.3538.4634.9923.2218.6719.6
Upgrade
Cash Income Tax Paid
353.76297.06283.71277.92220.22311.47
Upgrade
Levered Free Cash Flow
1,147891.34737.63806.96980.02107.23
Upgrade
Unlevered Free Cash Flow
1,172915.25759.62821.24991.87119.36
Upgrade
Change in Working Capital
-55.98-113.67-359.75-46.44263.45-380.95
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.